-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Afya, Lowers Price Target to $18

Benzinga·01/08/2026 18:17:22
語音播報
UBS analyst Andre Salles maintains Afya (NASDAQ:AFYA) with a Buy and lowers the price target from $19 to $18.